Coffee drinkers are far less likely to experience a recurrence of colon cancer, according to a major new observational study.
The study explored data from more than 1,700 patients with stage 1, 2 or 3 colorectal cancer (CRC) in The Netherlands.
After an approximately six-year median follow-up, coffee drinkers were reported to have a significantly lower rate of colon cancer recurrence, as well as a decreased incidence of death from any cause, compared to non coffee drinkers.
Published earlier this year in the International Journal of Cancer, the study adds to a mounting pile of evidence over the past decade suggesting that moderate coffee consumption can help stave off specific cancers — including cancers of the prostate, uterus and liver — as well as all-cause mortality.
Yet another study, led by researchers at Harvard and published in 2020, that found that coffee drinkers with advanced or metastatic colorectal cancer had an 11% higher survival rate during the study period.
The new study found that people who drank more than four cups of coffee per day were nearly one-third (32%) less likely to experience a return in colon cancer following treatment than those who drank less than two cups over a 6.2-year period.
In examining all-cause mortality (death from any cause), the researchers led by a team at Wageningen University in The Netherlands found a U-shaped correlation, with 3-5 cups per day being the optimal range for preventing death.
“The association between coffee consumption and all-cause mortality appeared nonlinear,” the researchers wrote. “More studies are needed to understand the mechanism by which coffee consumption might improve CRC prognosis.”
Comments? Questions? News to share? Contact DCN’s editors here.
Related Posts
